The impact of initial treatment delay using primary angioplasty on mortality among patients with acute myocardial infarction: From the Korea acute myocardial infarction registry

被引:26
作者
Bin Song, Young
Hahn, Joo-Yong
Gwon, Hyeon-Cheol [1 ]
Kim, Jun Hyung
Lee, Sang Hoon
Jeong, Myung-Ho [2 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Cardiac & Vasc Ctr,Dept Med, Seoul 135710, South Korea
[2] Chonnam Natl Univ Hosp, Ctr Heart, Kwangju, South Korea
关键词
myocardial infarction; mortality; angioplasty;
D O I
10.3346/jkms.2008.23.3.357
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The impact of treatment delays to reperfusion on patient mortality after primary percutaneous coronary intervention (PCI) for ST elevation myocardial infarction (STEMI) is controversial. We analyzed 5,069 patients included in the Korea Acute Myocardial Infarction Registry (KAMIR) between November 2005 and January 2007. We selected 1,416 patients who presented within 12 hr of symptom onset and who were treated with primary PCI. The overall mortality at one month was 4.4%. The medians of door-to-balloon time, symptom onset-to-balloon time, and symptom onset-to-door time were 90 (interquartile range, 65-136), 274 (185-442), and 163 min (90-285), respectively. One-month mortality was not increased significantly with any increasing delay in door-to-balloon time (4.3% for <= 90 min, 4.4% for > 90 min; p=0.94), symptom onset-to-balloon time (3.9% for <= 240 min, 4.8% for > 240 min; p=0.41), and symptom onset-to-door time (3.3% for <= 120 min, 5.0% for > 120 min; p=0.13). These time variables had no impact on one-month mortality in any subgroup. Thus, this first nationwide registry data in Korea showed a good result of primary PCI, and the patient prognosis may not depend on the initial treatment delay using the current protocols.
引用
收藏
页码:357 / 364
页数:8
相关论文
共 30 条
[1]   Task force 1: The ACCF and AHA codes of conduct in human subjects research [J].
Adams, RJ ;
Antman, EM ;
Kavey, REW .
CIRCULATION, 2004, 110 (16) :2512-2516
[2]   A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction [J].
Andersen, HR ;
Nielsen, TT ;
Rasmussen, K ;
Thuesen, L ;
Kelbaek, H ;
Thayssen, P ;
Abildgaard, U ;
Pedersen, F ;
Madsen, JK ;
Grande, P ;
Villadsen, AB ;
Krusell, LR ;
Haghfelt, T ;
Lomholt, P ;
Husted, SE ;
Vigholt, E ;
Kjaergard, HK ;
Mortensen, LS .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (08) :733-742
[3]  
[Anonymous], 1990, LANCET, V336, P65
[4]   Relation of time to treatment and mortality in patients with acute myocardial infarction undergoing primary coronary angioplasty [J].
Antoniucci, D ;
Valenti, R ;
Migliorini, A ;
Moschi, G ;
Trapani, M ;
Buonamici, P ;
Cerisano, G ;
Bolognese, L ;
Santoro, GM .
AMERICAN JOURNAL OF CARDIOLOGY, 2002, 89 (11) :1248-1252
[5]   INDICATIONS FOR FIBRINOLYTIC THERAPY IN SUSPECTED ACUTE MYOCARDIAL-INFARCTION - COLLABORATIVE OVERVIEW OF EARLY MORTALITY AND MAJOR MORBIDITY RESULTS FROM ALL RANDOMIZED TRIALS OF MORE THAN 1000 PATIENTS [J].
APPLEBY, P ;
BAIGENT, C ;
COLLINS, R ;
FLATHER, M ;
PARISH, S ;
PETO, R ;
BELL, P ;
HALLS, H ;
MEAD, G ;
DIAZ, R ;
PAOLASSO, E ;
PAVIOTTI, C ;
ROMERO, G ;
CAMPBELL, T ;
OROURKE, MF ;
THOMPSON, P ;
LESAFFRE, E ;
VANDEWERF, F ;
VERSTRAETE, M ;
ARMSTRONG, PW ;
CAIRNS, JA ;
MORAN, C ;
TURPIE, AG ;
YUSUF, S ;
GRANDE, P ;
HEIKKILA, J ;
KALA, R ;
BASSAND, JP ;
BOISSEL, JP ;
BROCHIER, M ;
LEIZOROVICZ, A ;
BRUGGEMANN, T ;
KARSCH, KR ;
KASPER, W ;
LAMMERTS, D ;
NEUHAUS, KL ;
MEYER, J ;
SCHRODER, R ;
VONESSEN, R ;
SARAN, RK ;
ARDISSINO, D ;
BONADUCE, D ;
BRUNELLI, C ;
CERNIGLIARO, C ;
FORESTI, A ;
FRANZOSI, MG ;
GUIDUCCI, D ;
MAGGIONI, A ;
MAGNANI, B ;
MATTIOLI, G .
LANCET, 1994, 343 (8893) :311-322
[6]   Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction - Results from the Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes (GUSTO-IIb) Trial [J].
Berger, PB ;
Ellis, SG ;
Holmes, DR ;
Granger, CB ;
Criger, DA ;
Betriu, A ;
Topol, EJ ;
Califf, RM .
CIRCULATION, 1999, 100 (01) :14-20
[7]   Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (Recombinant plasminogen activator) and front-loaded, accelerated alteplase (Recombinant tissue plasminogen activator) in patients with acute myocardial infarction [J].
Bode, C ;
Smalling, RW ;
Berg, G ;
Burnett, C ;
Lorch, G ;
Kalbfleisch, JM ;
Chernoff, R ;
Christie, LG ;
Feldman, RL ;
Seals, AA ;
Weaver, WD .
CIRCULATION, 1996, 94 (05) :891-898
[8]   Door-to-drug and door-to-balloon times: Where can we improve? Time to reperfusion therapy in patients with ST-segment elevation myocardial infarction (STEMI) [J].
Bradley, Elizabeth H. ;
Herrin, Jeph ;
Wang, Yongfei ;
McNamara, Robert L. ;
Radford, Martha J. ;
Magid, David J. ;
Canto, John G. ;
Blaney, Martha ;
Krumholz, Harlan M. .
AMERICAN HEART JOURNAL, 2006, 151 (06) :1281-1287
[9]   Impact of treatment delays on outcomes of primary percutaneous coronary intervention for acute myocardial infarction: Analysis from the CADILLAC trial [J].
Brodie, BR ;
Stone, GW ;
Cox, DA ;
Stuckey, TD ;
Turco, M ;
Tcheng, JE ;
Berger, P ;
Mehran, R ;
McLaughlin, M ;
Costantini, C ;
Lansky, AJ ;
Grines, CL .
AMERICAN HEART JOURNAL, 2006, 151 (06) :1231-1238
[10]   Door-to-balloon time with primary percutaneous coronary intervention for acute myocardial infarction impacts late cardiac mortality in high-risk patients and patients presenting early after the onset of symptoms [J].
Brodie, BR ;
Hansen, C ;
Stuckey, TD ;
Richter, S ;
VerSteeg, DS ;
Gupta, N ;
Downey, WE ;
Pulsipher, M .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (02) :289-295